I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Brigatinib in ALK-positive non-small cell lung cancer: real..:
Heredia, David
;
Barrón-Barrón, Feliciano
;
Cardona, Andrés Felipe
...
Future Oncology, 1744-8301, Vol. 17, Nro.2, 2021, p. 169-181. , 2021
Link:
https://hdl.handle.net/20.500.12495/5776
RT Journal T1
Brigatinib in ALK-positive non-small cell lung cancer: real-world data in the Latin American population (Bri-world extend CLICaP)
UL https://suche.suub.uni-bremen.de/peid=base-ftunivbosque:oai:repositorio.unbosque.edu.co:20.500.12495_5776&Exemplar=1&LAN=DE A1 Heredia, David A1 Barrón-Barrón, Feliciano A1 Cardona, Andrés Felipe A1 Campos, Saul T A1 Rodríguez-Cid, Jerónimo Rafael A1 Martínez-Barrera, Luis Manuel A1 Alatorre, Jorge A1 Salinas, Miguel Ángel A1 Lara-Mejía, Luis A1 Flores-Estrada, Diana A1 Arrieta, Oscar PB Future Medicine Ltd.; Future Oncology YR 2021 K1 Anaplastic lymphoma kinase K1 Brigatinib K1 Ceritinib K1 Crizotinib K1 Early access K1 Lung cancer K1 Non-small cell lung cancer K1 Real-world evidence JF Future Oncology, 1744-8301, Vol. 17, Nro.2, 2021, p. 169-181 LK http://dx.doi.org/https://hdl.handle.net/20.500.12495/5776 DO https://hdl.handle.net/20.500.12495/5776 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)